摘要:
The present invention provides Human Papilloma Virus (HPV) fusion proteins, linked to an immunological fusion partner that provides T helper epiptopes to the HPV antigen. Vaccine formulations are provided that are useful in the treatment or Prophylaxis of HPV induced tumours.
摘要:
A novel vaccine is presented for the prevention of Chlamydia infections utilising the outer membrane protein and two immunostimulants, 3D-MPL and QS21.
摘要:
A novel vaccine is presented for the prevention of Chlamydia infections utilising the outer membrane protein and two immunostimulants, 3D-MPL and QS21.
摘要:
The present invention provides vaccine compositions comprising 3 De-O-acylated monophosphoryl lipid A and QS21. The vaccines compositions are potent inducers of CTL and gamma IFN responses.
摘要:
Novel herpes simplex (HSV) vaccine formulations are provided. These comprise HSV glycoprotein gD or immunological fragments in conjunction with 3 Deacylated monophosphoryl lipid A.
摘要:
The present invention provides vaccine compositions comprising 3 De-O-acylated monophosphoryl lipid A and QS21. The vaccines compositions are potent inducers of CTL and gamma IFN responses.
摘要:
Nouveaux antigènes utiles dans les formulations vaccinales destinées au traitement prophylactique d'une série de maladies infectieuses. Les antigènes sont constitués d'un polypeptide hybride dont l'une des parties est l'antigène S du virus de l'hépatite B, et dont l'autre partie est un antigène hétérologue tel que le gD de HSV. Les deux antigènes sont reliés l'un à l'autre par des segments intercalaires chimiques par l'intermédiaire d'un groupe sulfydryle natif présent à la surface de l'antigène S.
摘要:
The present invention relates to the field of bacterial polysaccharide antigen vaccines. Streptococcus pneumoniae, and optionally a Th1-inducing adjuvant.
摘要:
Novel herpes simplex (HSV) vaccine formulations are provided. These comprise HSV glycoprotein gD or immunological fragments in conjunction with 3 Deacylated monophosphoryl lipid A.
摘要:
The present invention provides a method of inducing or enhancing an immune response to polysaccharides or other T cell-independent antigen by the coadministration of the antigen with bacterial lipoproteins (including covalent attachment of the antigen and lipoproteins). In a preferred embodiment, the lipoprotein of the invention is lipoprotein D.